References
- Saunders R. N., Metcalfe M. S., Nicholson M. L. Rapamycin in transplantation: a review of evidence. Kidney Int, 2001, 59: 3.
- Mahé M., Morelon E., Lechaton S. Cutaneous adverse events in renal transplant recipients of sirolimus-based therapy. Transplantation, 2005, 79: 476–482.
- Porter S., Scully C. Aphthous ulcers (recurrent) in clinical evidence, 2005, 14: 1678–1684.
- Scully C. Aphthous ulceration. New Engl J Med, 2006, 355: 165–172.
- MacDonald A. S., Rapamune Global Study Group. A worldwide, phase III, randomised, controlled, safety and efficacy study of a sirolimus/ciclosporin regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation, 2001, 71: 271.
- Kahan B. D. Efficacy of sirolimus compared with azathioprine for the reduction of acute renal allograft rejection: a randomised multi-centre study. The Rapamune US Study Group. Lancet, 2000, 356: 194.
- Van Gelder T., ter Meulen C. G., Hene R. et al. Oral ulcers in kidney transplant recipients treated with sirolimus and mycopheno-late mofetil. Transplantation, 2003, 75: 788.
- Bencini P. L., Montagnino G., Scala F. et al. Cutaneous lesions in 67 ciclosporin-treated renal transplant recipients. Dermatologica, 1986, 172: 24.